Neurology ReviewsEating Fish May Be Associated With a Reduced Risk of MSApril 23, 2018Multiple Sclerosis
Clinical Neurology NewsBlood-brain barrier health may signal early loss of MS treatment responseApril 20, 2018Multiple Sclerosis
Clinical Neurology NewsRare, serious alemtuzumab adverse events emergeApril 11, 2018Multiple Sclerosis
Neurology ReviewsUpdates in MS: Highlights From the ECTRIMS and ACTRIMS Annual MeetingsApril 11, 2018Multiple Sclerosis
Neurology ReviewsHigh Dose of Novel Compound Shows Promise for Relapsing-Remitting MSApril 4, 2018Multiple Sclerosis
Neurology ReviewsWhat Is the Mechanism of Alemtuzumab-Induced Autoimmunity?April 4, 2018Multiple Sclerosis
Neurology ReviewsPatients With MS May Not Receive Appropriate Medicines From Primary Care DoctorsApril 4, 2018Multiple Sclerosis
Neurology ReviewsExtended-Interval Dosing of Natalizumab Is Associated With Reduced PML RiskApril 3, 2018Multiple Sclerosis
Neurology ReviewsClean-Surfaced Nanocrystalline Gold May Promote RemyelinationApril 2, 2018Multiple Sclerosis
Neurology ReviewsNatalizumab May Be Associated With Increased Disease Activity During PregnancyApril 2, 2018Multiple Sclerosis
Neurology ReviewsAre Complementary and Alternative Treatments Effective for MS?April 2, 2018Multiple Sclerosis
Clinical Neurology NewsFrankincense extract may reduce disease activity in relapsing-remitting MSMarch 27, 2018Multiple Sclerosis
